Global Market Study on Generic Oncology Drugs

Nov 2018| PMR1061A| Persistence Market Research

Report Highlights

A recent market study published by the company titled “Generic Oncology Drugs Market: Global Industry Analysis 2013–2017 and Forecast 2018–2028” consists of a comprehensive assessment of the most important dynamics of the Generic Oncology Drugs market. Upon conducting comprehensive research on the current growth parameters of the Generic Oncology Drugs market, the growth prospects of the market are obtained with maximum precision. The report features the unique and salient factors that are likely to have a significant impact on the development of the concerned market during the forecast period. The report provides detailed information about the current and future growth prospects of the concerned market in the most comprehensive manner for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with an executive summary of the Generic Oncology Drugs market report, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) of the leading segments of the Generic Oncology Drugs market.

Chapter 2 – Market Introduction

Readers can find a detailed taxonomy and definition of Generic Oncology Drugs products in this chapter, which will help them understand the basic information about the concerned market. The definition section considers the factors included as well as excluded for the purpose of this report.

Chapter 3 – Market Opportunity Analysis

This section of the report provides readers an outlook of the global Generic Oncology Drugs market, taking into consideration the various factors associated with the growth, which will help them track the current market scenario, with key inferences drawn from historical data, current trends and future prospects. This section also consists of an opportunity analysis conducted by PMR. Readers can find various macro-economic factors associated with the growth of the market

Chapter 4 – Market Background

This chapter highlights the key market dynamics, which include the drivers, restraints and trends. In this chapter, readers can understand the factors that are propelling the growth of the market along with the factors that are likely to deter the growth of the market. Moreover, readers will understand the key trends followed by the leading manufacturers in the Generic Oncology Drugs market. Key pointers, such as PESTLE Analysis and Regulatory Scenario, are also included in the report.

Chapter 5 – Key Inclusions

This chapter shows the Generic Oncology Drugs Pipeline on a much broader scale with regular details.

Chapter 6 – North America Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes a detailed analysis of the growth of the North America Generic Oncology Drugs market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find historical trends and market attractiveness based on molecule type, route of administration and distribution channel for the North America region.

Chapter 7 – Western Europe Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

Important growth prospects of the Generic Oncology Drugs market with market attractiveness based on molecule type, route of administration and distribution channel in several Western European countries, such as Spain, UK, Germany, Italy, France and the Rest of Western Europe, are included in this chapter.

Chapter 8 – Eastern Europe Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

Important growth prospects of the Generic Oncology Drugs market with market attractiveness based on molecule type, route of administration and distribution channel in several Eastern European countries.

Chapter 9 – Latin America Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes a detailed analysis of the growth of the Latin America Generic Oncology Drugs market along with a country-wise assessment that includes Brazil and Mexico. Readers can also find historical trends and market attractiveness based on molecule type, route of administration and distribution channel of Generic Oncology Drugs in the Latin American region.

Chapter 10 – APECJ Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

India, ASEAN and Australia & New Zealand are the leading countries in the APECJ region that are the prime subject of assessment to obtain growth prospects for the APECJ Generic Oncology Drugs market. In this chapter, readers can find detailed information about the growth parameters.

Chapter 11 – China Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

Readers can find important factors that can have a significant impact on the growth of the Generic Oncology Drugs market in China based on molecule type, route of administration and distribution channel of Generic Oncology Drugs during the forecast period

Chapter 12 – Japan Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

Readers can find important factors that can have a significant impact on the growth of the Generic Oncology Drugs market in Japan based on the market segmentation during the forecast period.

Chapter 13 – MEA Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028

This chapter provides information about how the Generic Oncology Drugs market will grow in the major countries in the MEA region, such as GCC Countries and South Africa, during the period 2013-2028.

Chapter 14 – Forecast Factors: Relevance and Impact

 Forecast factors set for the estimation of the entire concerned market are also present in this section.

Chapter 15 – Forecast Assumptions

Global assumptions taken in order to obtain the market size and scenario for Generic Oncology Drugs market

Chapter 16 – Competition Analysis

In this chapter, along with detailed information about each company, including company overview, revenue shares, strategic overview and recent company developments for Generic Oncology Drugs. Market players featured in this report include Novartis, Pfizer, GSK, Celegne, Teva Pharmaceutical, Merck & Company, Aurobindo Pharma, Hikma Pharmaceuticals, Mylan and Natco Pharma

Chapter 17 – Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Region

This section highlights Global Generic Oncology Drugs value in different regions, the overall global market value (US$ Mn), forecast and analysis.

Based on the Region, the Generic Oncology Drugs market is segmented into North America, Latin America, Western Europe, Eastern Europe, APECJ, Japan, China and MEA.

Chapter 18 – Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Molecule Type

Based on Molecule Type, the Global Generic Oncology Drugs market is segmented into large molecule and small molecule.

Chapter 19 – Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration

Based on Route of Administration, the Global Generic Oncology Drugs market is segmented into Oral and Parenteral.

Chapter 20 – Global Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

Based on Distribution Channel, the Global Generic Oncology Drugs market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Managed Care Institutions.

Chapter 21 – Global Generic Oncology Drugs Market Analysis and Forecast

This section highlights the Generic Oncology Drugs market value, the overall global Absolute $ Opportunity, forecast and analysis.

Chapter 22 – Assumptions and Acronyms Used

This section consists of a glossary of assumptions and acronyms used in the Generic Oncology Drugs market report.

Chapter 23 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information and quantitative information about the Generic Oncology Drugs market.

  • Table 1 : Generic Oncology Drugs Expected to be Launched by end of 2018
  • Table 2 : North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Country
  • Table 3 : North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 4 : North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 5 : North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Table 6 : Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Country
  • Table 7 : Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 8 : Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 9 : Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Table 10 : Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Country
  • Table 11 : Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 12 : Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 13 : Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Table 14 : Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Country
  • Table 15 : Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 16 : Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 17 : Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Table 18 : APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Country
  • Table 19 : APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 20 : APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 21 : APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Table 22 : China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 23 : China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 24 : China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Table 25 : China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 26 : China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 27 : China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Table 28 : MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Country
  • Table 29 : MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 30 : MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 31 : MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Table 32 : Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Region
  • Table 33 : Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Molecule Type
  • Table 34 : Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Route of Administration
  • Table 35 : Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2028, By Distribution Channel
  • Figure 1 : Generic Oncology Drugs Market Value Share By Region (2018)
  • Figure 2 : Global Generic Oncology Drugs Market Share, By Region (2017)
  • Figure 3 : Global Generic Oncology Drugs Market Share, By Molecule Type (2017)
  • Figure 4 : Global Generic Oncology Drugs Market Share, By Route of Administration Type (2017)
  • Figure 5 : Global Generic Oncology Drugs Market Share, By Distribution Channel (2017)
  • Figure 6 : Distribution of Industry Sponsored Clinical Programs for Generic Oncology Drugs, by Phase
  • Figure 7 : Number of Active Clinical Programs, by Major Indications
  • Figure 8 : Geographical Distribution of Clinical Trials for Meningococcal Vaccines (2017)
  • Figure 9 : North America Generic Oncology Drugs Market, Snapshot
  • Figure 10 : North America Generic Oncology Drugs Market Value Share, by Country (2017)
  • Figure 11 : North America Generic Oncology Drugs Market Value Share, by Molecule Type (2017)
  • Figure 12 : North America Generic Oncology Drugs Market Value Share, by Distribution Channel (2017)
  • Figure 13 : North America Generic Oncology Drugs Market Value Share, By Route of Administration (2017)
  • Figure 14 : North America Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 15 : North America Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 16 : North America Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 17 : North America Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 18 : North America Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 19 : North America Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 20 : Latin America Generic Oncology Drugs Market, Snapshot
  • Figure 21 : Latin America Generic Oncology Drugs Market Value Share, by Country (2017)
  • Figure 22 : Latin America Generic Oncology Drugs Market Value Share, by Molecule Type (2017)
  • Figure 23 : Latin America Generic Oncology Drugs Market Value Share, by Distribution Channel (2017)
  • Figure 24 : Latin America Generic Oncology Drugs Market Value Share, By Route of Administration (2017)
  • Figure 25 : Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 26 : Latin America Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 27 : Latin America Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 28 : Latin America Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 29 : Latin America Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 30 : Latin America Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 31 : Western Europe Generic Oncology Drugs Market, Snapshot
  • Figure 32 : Western Europe Generic Oncology Drugs Market Value Share, by Country (2017)
  • Figure 33 : Western Europe Generic Oncology Drugs Market Value Share, by Molecule Type (2017)
  • Figure 34 : Western Europe Generic Oncology Drugs Market Value Share, by Distribution Channel (2017)
  • Figure 35 : Western Europe Generic Oncology Drugs Market Value Share, By Route of Administration (2017)
  • Figure 36 : Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 37 : Western Europe Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 38 : Western Europe Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 39 : Western Europe Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 40 : Western Europe Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 41 : Western Europe Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 42 : Eastern Europe Generic Oncology Drugs Market, Snapshot
  • Figure 43 : Eastern Europe Generic Oncology Drugs Market Value Share, by Country (2017)
  • Figure 44 : Eastern Europe Generic Oncology Drugs Market Value Share, by Molecule Type (2017)
  • Figure 45 : Eastern Europe Generic Oncology Drugs Market Value Share, by Distribution Channel (2017)
  • Figure 46 : Eastern Europe Generic Oncology Drugs Market Value Share, By Route of Administration (2017)
  • Figure 47 : Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 48 : Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 49 : Eastern Europe Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 50 : Eastern Europe Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 51 : Eastern Europe Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 52 : Eastern Europe Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 53 : APECJ Generic Oncology Drugs Market, Snapshot
  • Figure 54 : APECJ Generic Oncology Drugs Market Value Share, by Country (2017)
  • Figure 55 : APECJ Generic Oncology Drugs Market Value Share, by Molecule Type (2017)
  • Figure 56 : APECJ Generic Oncology Drugs Market Value Share, by Distribution Channel (2017)
  • Figure 57 : APECJ Generic Oncology Drugs Market Value Share, By Route of Administration (2017)
  • Figure 58 : APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 59 : APECJ Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 60 : APECJ Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 61 : APECJ Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 62 : APECJ Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 63 : APECJ Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 64 : China Generic Oncology Drugs Market, Snapshot
  • Figure 65 : China Generic Oncology Drugs Market Value Share, by Molecule Type (2017)
  • Figure 66 : China Generic Oncology Drugs Market Value Share, by Route of Administration (2017)
  • Figure 67 : China Generic Oncology Drugs Market Value Share, By Distribution Channel (2017)
  • Figure 68 : China Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 69 : China Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 70 : China Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 71 : China Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 72 : China Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 73 : Japan Generic Oncology Drugs Market, Snapshot
  • Figure 74 : Japan Generic Oncology Drugs Market Value Share, By Molecule Type (2017)
  • Figure 75 : Japan Generic Oncology Drugs Market Value Share, By Route of Administration (2017)
  • Figure 76 : Japan Generic Oncology Drugs Market Value Share, By Distribution Channel (2017)
  • Figure 77 : Japan Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 78 : Japan Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 79 : China Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 80 : China Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 81 : China Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 82 : Middle East & Africa Generic Oncology Drugs Market, Snapshot
  • Figure 83 : MEA Generic Oncology Drugs Market Value Share, by Molecule Type (2017)
  • Figure 84 : MEA Generic Oncology Drugs Market Value Share, by Country (2017)
  • Figure 85 : MEA Generic Oncology Drugs Market Value Share, by Distribution Channel (2017)
  • Figure 86 : MEA Generic Oncology Drugs Market Value Share, By Route of Administration (2017)
  • Figure 87 : Middle East & Africa Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 88 : Middle East & Africa Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 89 : MEA Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 90 : MEA Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 91 : MEA Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 92 : MEA Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 93 : Global Generic Oncology Drugs Market Attractiveness Analysis, By Region
  • Figure 94 : Global Generic Oncology Drugs Market Value Share Analysis, By Region, 2017 & 2028
  • Figure 95 : Global Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 96 : Global Generic Oncology Drugs Market Value Share Analysis, By Molecule Type, 2017 & 2028
  • Figure 97 : Global Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 98 : Global Generic Oncology Drugs Market Value Share Analysis, By Route of Administration, 2017 & 2028
  • Figure 99 : Global Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 100 : Global Generic Oncology Drugs Market Value Share Analysis, By Distribution Channel, 2017 & 2028
  • Figure 101 : Global Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 102 : Global Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2028
  • Figure 103 : Global Generic Oncology Drugs Market Absolute $ Opportunity, 2013�2028

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report